PUMA BIOTECHNOLOGY, INC. Logo

PUMA BIOTECHNOLOGY, INC.

A biopharmaceutical company developing and commercializing novel cancer therapeutics.

PBYI | US

Overview

Corporate Details

ISIN(s):
US74587V1070
LEI:
Country:
United States of America
Address:
10880 WILSHIRE BLVD., 90024 LOS ANGELES

Description

Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer. The company's primary commercial product is Nerlynx® (neratinib), an FDA-approved oral medication for certain types of breast cancer. Its clinical pipeline includes alisertib, an investigational drug being evaluated in clinical trials for small cell lung cancer and metastatic breast cancer. The company's mission is to develop and commercialize innovative products to enhance cancer care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-13 17:41
FORM 4
English ZIP 7.3 KB
2025-11-12 09:29 English ZIP 7.2 KB
2025-11-06 17:41
FORM 10-Q
English ZIP 1.5 MB
2025-11-06 17:16
FORM 8-K
English ZIP 114.6 KB
2025-08-07 18:41
FORM 10-Q
English ZIP 1.6 MB
2025-08-07 18:32
FORM 8-K
English ZIP 113.8 KB
2025-08-06 23:35
FORM 10-Q/A
English ZIP 84.6 KB
2025-07-22 21:51
FORM 4
English ZIP 7.2 KB
2025-07-18 18:16 English ZIP 7.3 KB
2025-07-10 22:56
FORM 4
English ZIP 6.8 KB
2025-07-10 22:52
FORM 4
English ZIP 6.9 KB
2025-07-10 22:49
FORM 4
English ZIP 6.8 KB
2025-07-09 18:48 English ZIP 7.4 KB
2025-07-09 18:36 English ZIP 7.3 KB
2025-07-09 18:27 English ZIP 7.4 KB

Automate Your Workflow. Get a real-time feed of all PUMA BIOTECHNOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PUMA BIOTECHNOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PUMA BIOTECHNOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.